Alan Sher – Iron metabolism as a target for host-directed therapy of tuberculosis

Max Planck Seminar

  • Date: Dec 1, 2017
  • Time: 13:00 c.t. - 14:00
  • Speaker: Alan Sher
  • NIH Distinguished Investigator, Bethesda, USA
  • Location: MPI-IE
  • Room: Main Lecture Hall
  • Host: Erika Pearce
Alan Sher – Iron metabolism as a target for host-directed therapy of tuberculosis
NIH Researcher Alan Sher, PhD will visit Freiburg and joins the Max Planck Seminar Series at December 1st, 2017. The talk is entitled “Iron metabolism as a target for host-directed therapy of tuberculosis”. Begin is at 1pm in the Main Lecture Hall of the MPI-IE.

About Alan Sher's research at the National Institute of Allergy and Infectious Diseases (NIAID/NIH):

“The Immunobiology Section studies host resistance and immune regulation in parasitic and other infections of global importance. The ultimate goal of this work is immunologic disease intervention in the form of vaccination or immunotherapy. At the same time, our research on the host response to infection has provided insights into the effector functions and regulatory mechanisms used by the vertebrate immune system and in the role of innate pathogen recognition in these processes. Much of the work of the section is focused on the immunologic analysis in murine models of diseases induced by parasitic and bacterial agents (e.g., Toxoplasma gondii, Mycobacterium spp.), although the group is also engaged in several major clinical collaborations. The lab also has a major interest in the regulation of Th1-dependent immunopathology in T. gondii and mycobacterial infections as well as tuberculosis-HIV co-infection.”

(source: NIH)

Go to Editor View